Journal of Clinical Microbiology · 1998 · 211 citations · 27 references
Life SciencesInfectious DiseasesMicrobiologyImmunizationMolecular VirologyVirologyVaccinationVaccine-preventable DiseasesViral GenomicsViral InfectionsViral VaccinesAntigenic Variation In VirusesOral Polio VaccinationPolio Elimination StrategyPoliovirus VaccinationPoliovirus VaccinesRelative Synonymous Codon UsageSynonymous Codon SubstitutionVaccination In Primary Immunodeficiency
VP1 sequences were determined from poliovirus type 1 isolates collected over 189 days from a patient with common variable immunodeficiency. The first sample, 11 days after paralysis onset, contained two distinct poliovirus populations differing from the Sabin 1 vaccine strain by ~10 % and from wild strains by 19–24 %, while later samples showed a single dominant population, and VP1 evolution at synonymous sites occurred at ~3.4 % per year, suggesting the infection began ~9.3 years earlier—around the time of the patient’s last oral vaccine dose—highlighting implications for post‑eradication poliovirus immunization strategies.
VP1 sequences were determined for poliovirus type 1 isolates obtained over a 189-day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in antibody formation). The isolate from the first sample, taken 11 days after onset of paralysis, contained two poliovirus populations, differing from the Sabin 1 vaccine strain by approximately 10%, differing from diverse type 1 wild polioviruses by 19 to 24%, and differing from each other by 5.5% of nucleotides. Specimens taken after day 11 appeared to contain only one major poliovirus population. Evolution of VP1 sequences at synonymous third-codon positions occurred at an overall rate of approximately 3.4% per year over the 189-day period. Assuming this rate to be constant throughout the period of infection, the infection was calculated to have started approximately 9.3 years earlier. This estimate is about the time (6. 9 years earlier) the patient received his last oral poliovirus vaccine dose, approximately 2 years before the diagnosis of immunodeficiency. These findings may have important implications for the strategy to eliminate poliovirus immunization after global polio eradication.
27
PHYLIP-Phylogeny inference package (Version 3.2)
Joe Felsenstein · Cladistics · 1989 · 17.9K citations
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
James M. Hogle, M Chow, David J. Filman · Science · 1985 · 1.3K citations